BRL-101
2024-BRL-101-SCD-01
Unknown small_molecule active
Quick answer
BRL-101 for Sickle Cell Disease is a Unknown program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Sickle Cell Disease
- Phase
- Unknown
- Modality
- small_molecule
- Status
- active